Search

Zai Lab Ltd ADR

Chiusa

SettoreSettore sanitario

26.37 -0.08

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

26.32

Massimo

26.88

Metriche Chiave

By Trading Economics

Entrata

191K

-51M

Vendite

6.7M

106M

EPS

-0.46

Margine di Profitto

-47.808

Dipendenti

1,784

EBITDA

-2.1M

-46M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+48.82% upside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

914M

3B

Apertura precedente

26.45

Chiusura precedente

26.37

Notizie sul Sentiment di mercato

By Acuity

38%

62%

80 / 339 Classifica in Healthcare

Zai Lab Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 set 2026, 23:55 UTC

News

Roivant Sciences Ltd is higher in after-market trading following positive Phase 2 trial results for mosliciguat, showing significant improvements in pulmonary hypertension patients.

22 set 2026, 23:51 UTC

News

Itron Inc's stock is declining in after-market trading, despite the launch of its Riva IEC Grid Edge Portfolio in the Asia Pacific region.

22 set 2026, 23:50 UTC

News

Coeur Mining plans a record $158 million exploration investment for 2026, more than double 2025's budget, as shares rise in after-market trading.

22 set 2026, 23:41 UTC

Social Media
Event
News

NN, Inc. raised its 2026 net sales guidance to $470M-$490M and adjusted EBITDA to $58M-$68M, leading to a sharp after-market hours increase.

22 set 2026, 23:35 UTC

News

Tencent Music Entertainment Group's shares rose in after-market trading, maintaining a strong performance above the 20-day moving average since Tuesday's close.

22 set 2026, 23:35 UTC

News

Quest Diagnostics will release third-quarter results on October 22, 2026, and is modestly higher in after-market trading since Tuesday's close.

22 set 2026, 23:31 UTC

Correlated Moves
News

Dynex Capital Inc announced a public offering of 4.8M shares of preferred stock, expected to raise $120 million, with shares trading higher in after-market hours.

22 set 2026, 23:31 UTC

News

Peloton Interactive Inc. plans to launch the "Tread Flex" treadmill as part of its turnaround strategy, contributing to modest gains in after-market trading.

22 set 2026, 23:25 UTC

News

Domo Inc completes asset sale to Progress Software, rebranding as Huckleberry.ai, and is now debt-free with $221 million in cash, shares advancing in after-market trading.

22 set 2026, 23:21 UTC

Social Media
News

Meta's Muse AI app tops U.S. App Store, leading to after-market gains as analysts raise price targets to $820 and $796 amid strong user engagement.

22 set 2026, 23:10 UTC

News

Shares declined in after-market trading; implied volatility at yearly low.

22 set 2026, 23:10 UTC

News

General Electric Co is trading slightly higher in after-market hours, supported by a $170 billion commercial services backlog and strong pricing power.

22 set 2026, 23:10 UTC

News

RTX Corp received a $105.6 million contract modification from the U.S. Department of War for missile parts, with work expected to complete by August 31, 2027.

22 set 2026, 23:10 UTC

News

V2X Inc received a $231.8 million contract modification from the U.S. Air Force, raising total contract value to $594.2 million, boosting stock in after-market trading.

22 set 2026, 23:06 UTC

News

Home Depot announced a partnership with TP-Link to offer exclusive Tapo smart home security camera bundles in 500 stores and online, with shares roughly flat in after-market trading.

22 set 2026, 23:06 UTC

News

Microsoft will consider shareholder proposals at its annual meetings, following an agreement with activist Paul Chesser, and is trading higher in after-market hours.

22 set 2026, 23:06 UTC

News

General Motors Co is trading lower in after-market hours, having retraced from earlier gains and falling below its 20-day moving average.

22 set 2026, 23:06 UTC

News

Verizon Communications Inc. is seeing a modest increase in after-market trading, bolstered by the launch of a new 5G handset and expanded 6G research partnerships.

22 set 2026, 23:06 UTC

News

XRP has gained traction, supported by positive trading posts and recent performance in liquidity pools, despite pulling back from earlier session highs.

22 set 2026, 23:06 UTC

News

Eli Lilly's stock is higher in after-market trading as the company begins construction on a $6.5 billion facility for its oral GLP-1 drug, Foundayo.

22 set 2026, 23:05 UTC

News

Star Bulk Carriers is trading higher in after-market hours, rebounding from a dip, as Alexandros Pappas purchased $2.1 million in stock at $28.27 per share.

22 set 2026, 23:01 UTC

News

Intercontinental Exchange Inc. has launched a private credit reference data service for institutional clients, contributing to its gains in after-market trading.

22 set 2026, 23:01 UTC

News
Social Media

Brighthouse Financial's shares rose in after-market trading as Sixth Street reiterated its interest in acquiring the company amid regulatory delays with another buyer.

22 set 2026, 23:01 UTC

Social Media
News

CME Group plans to introduce Bitcoin Cash and Uniswap futures on October 19, pending regulatory approval, as its stock moves higher in after-market trading.

22 set 2026, 23:01 UTC

News

CF Industries Holdings Inc is advancing in after-market trading, recovering from recent declines amid concerns over a potential potash supply deal with Belarus.

22 set 2026, 23:01 UTC

Event
News

Worthington Enterprises reported Q1 fiscal 2027 net sales of $343.9 million and EPS of $0.87, exceeding expectations, driving the stock sharply higher in after-market trading.

22 set 2026, 23:01 UTC

Social Media
News

Sharp decline in revenues and net income leads to after-hours drop.

22 set 2026, 23:01 UTC

News

General Mills Inc's adjusted diluted EPS is projected between $3 and $3.20, with shares moving modestly higher in after-market trading.

22 set 2026, 23:01 UTC

News

Credit Acceptance Corporation appointed Shannon Wilson as Chief Human Resources Officer, effective September 28, 2026, contributing to an upward move in after-market trading.

22 set 2026, 23:01 UTC

News

Williams-Sonoma Inc's market capitalization is $27.41 billion, with the stock showing a notable increase in after-market trading, continuing a five-session positive trend.

Confronto tra pari

Modifica del prezzo

Zai Lab Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

48.82% in crescita

Previsioni per 12 mesi

Media 39.333 USD  48.82%

Alto 45 USD

Basso 36 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zai Lab Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

80 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.